Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners
Tribe Technology set to deliver healthy pipeline of orders from Tier-One minersView Video
Andrada Mining acquisition elevates the miner to emerging mid-tier status
Andrada Mining acquisition elevates the miner to emerging mid-tier statusView Video

Latest Share Chat

Pin to quick picksSanofi Share News (SAN.PA)

Share Price Information for Sanofi (SAN.PA)

Euronext Paris
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 89.94
Bid: 93.35
Ask: 93.36
Change: 0.08 (0.089%)
Spread: 0.01 (0.011%)
Open: 90.23
High: 90.59
Low: 89.73
Prev. Close: 89.86
SAN.PA Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

European shares slip overall but German blue-chips hit record high

Fri, 28th Jul 2023 17:31

STOXX 600 dips 0.2% but posts weekly gains

*

Germany's DAX hits record high

*

BOJ policy tweak lifts European yields

*

Capgemini slides as Q2 growth slows

July 28 (Reuters) - European shares retreated from multi-month highs on Friday after a mixed bag of earnings and a surprise Bank of Japan policy tweak, but German blue-chips bucked the trend to close at a record high on signs of cooling inflation.

The pan-European STOXX 600 index ended 0.2% lower after closing at its highest level in nearly 1-1/2 years on Thursday when the European Central Bank hiked interest rates as expected but raised the possibility of a pause in September.

Rattling investor nerves, the BoJ made its yield curve control policy more flexible and loosened its defence of a long-term interest rate cap, in moves seen as a prelude to an eventual shift away from the massive monetary stimulus.

"We have the last of the accommodative central banks moving away from accommodative policies," said Steve Sosnick, chief strategist at Interactive Brokers.

"The fear of this BOJ move was because it can really affect hedge funds' carry trade...there was a fear that this could really spiral out from Japan yields (but) it hasn't happened."

Germany's DAX index hit an intraday record and held on to most of the gains to close 0.39% higher after data showed inflation resumed a downward trend in Europe's largest economy.

However, separate data showed the economy stagnated in the second quarter of 2023, missing forecasts for modest growth

Elsewhere, Spanish consumer prices rose by a more than anticipated 2.3% in the 12 months through July.

Despite Friday's weakness, the benchmark STOXX 600 notched up a third straight week of gains, on hopes that the Federal Reserve and the ECB are nearly done hiking interest rates.

Tech stocks and miners were among the week's top gainers, adding 3.6% and 3.4% respectively.

Hermes rose 3.9% as sales at the Birkin bag maker accelerated in the second quarter, while AstraZeneca advanced 3.3% after reporting forecast-beating profit and sales.

French drugmaker Sanofi slipped 2.9% as quarterly sales fell short of estimates, and French IT consulting group Capgemini tumbled 7.0% on a bigger-than-expected slowdown in second-quarter growth.

Austrian sensor maker AMS Osram jumped 18.5% after the company presented a strategic re-alignment of the group and reported second-quarter results in line with its expectations.

Pan-European stock and derivatives exchange Euronext climbed 7.4%, boosted by the launch of a 200-million-euro ($219.88 million) share buyback programme. (Reporting by Sruthi Shankar, Amruta Khadekar and Shristi Achar A in Bengaluru; Editing by Kirsten Donovan)

More News
10 Jul 2023 19:33

EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported

July 10 (Reuters) - The European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.

Read more
5 Jul 2023 12:04

China extends squeezed-out foreign pharmaceuticals firms an olive branch

BEIJING, July 5 (Reuters) - China's Commerce Minister told foreign pharmaceuticals firms they can expect "more development opportunities" during a roundtable on Wednesday, his ministry said, as drugmakers bemoan government procurement policies pricing them out of the market.

Read more
30 Jun 2023 22:38

First trial over Zantac cancer claims set for November

June 30 (Reuters) - The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state court on Nov. 13, a lawyer for plaintiffs in the litigation said Friday.

Read more
29 Jun 2023 06:30

Sanofi says it's back to the drawing board on mRNA flu vaccines

June 29 (Reuters) - Sanofi said that trials show the currently available mRNA technology behind the most successful COVID-19 shots will not be effective against influenza and it is already working on a next generation of shots.

Read more
23 Jun 2023 20:24

GSK soothes investors by settling first Zantac cancer lawsuit due for US trial

GSK shares best performer on London's stock market

*

Read more
22 Jun 2023 14:02

Novo Nordisk says EMA raised safety signal on drugs including semaglutide

Signal included drugs from Eli Lilly, AstraZeneca, Sanofi

*

Read more
22 Jun 2023 08:54

Novo Nordisk shares slip on EMA drug safety signal

COPENHAGEN, June 22 (Reuters) - Novo Nordisk said on Thursday the European Union's drug watchdog had last month raised a thyroid cancer safety signal for several of its drugs including semaglutide, the active ingredient in its popular diabetes and obesity drugs, Ozempic and Wegovy.

Read more
20 Jun 2023 17:44

China-exposed miners, luxury shares drag STOXX 600 down; Lanxess plunges

China-exposed miners and luxury stocks weigh

*

Read more
31 May 2023 23:35

US FDA approves Pfizer's RSV vaccine

May 31 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors.

Read more
27 Apr 2023 12:36

AstraZeneca increases bets on China as COVID vaccine sales fade

AstraZeneca already biggest drugmaker in China

*

Read more
27 Mar 2023 23:51

Amgen-Sanofi patent case divides makers of antibody drugs

March 27 (Reuters) - Amgen Inc's battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape U.S. patent law and competition among companies that make antibody medicines.

Read more
24 Mar 2023 15:25

GSK loses bid to keep experts out of upcoming Zantac trial

March 24 (Reuters) - A California judge on Thursday denied GSK Plc's bid to keep expert testimony linking its discontinued heartburn drug Zantac to cancer out of an upcoming trial, a setback for the British drugmaker facing lawsuits over the medicine in courts across the United States.

Read more
23 Mar 2023 17:09

Banks drag European shares down as c.banks join Fed in raising rates

Banks down 2.4%, rate-sensitive tech up 2.2%

*

Read more
20 Mar 2023 06:00

Vaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in supplies

LONDON, March 20 (Reuters) - Some of the world's leading makers of flu vaccines say they could make hundreds of millions of bird flu shots for humans within months if a new strain of avian influenza ever jumps across the species divide.

Read more
13 Mar 2023 17:13

European stocks log steepest one-day fall this year as banks extend slide

European banks log worst two-day selloff in a year

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.